An imprint method for detecting leptospires in the hamster model of vaccine-mediated immunity for leptospirosis

Journal of Medical Microbiology

Volumn 58, Issue 12, 2009, Pages 1632-1637

  Chagas Junior, Adenizar D ^a   McBride, Alan J A ^a   Athanazio, Daniel A ^a,b   Figueira, Cláudio P ^a   Medeiros, Marco A ^a   Reis, Mitermayer G ^a   Ko, Albert I ^a,c   McBride, Flávia W C ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; IMMUNOLOGICAL ADJUVANT; LEPTOSPIROSIS VACCINE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD SAMPLING; CONTROLLED STUDY; DRUG SCREENING; EXPERIMENTAL INFECTION; FEMALE; HAMSTER; HISTOPATHOLOGY; IMMUNIZATION; IMPRINT METHOD; INTERMETHOD COMPARISON; KIDNEY PARENCHYMA; LEPTOSPIRA; LEPTOSPIROSIS; LIVER; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL VACCINES; CRICETINAE; FEMALE; KIDNEY; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LIVER; LUNG; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 73449104728     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.014050-0     Document Type: Article

References (39)

1. Adler, B. & de la Pena Moctezuma, A. (2009). Leptospira and leptospirosis. Vet Microbiol 2009 Mar 13 [Epub ahead of print].
2. Athanazio, D. A., Silva, E. F., Santos, C. S., Rocha, G. M., Vannier-Santos, M. A., McBride, A. J., Ko, A. I. & Reis, M. G. (2008). Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop 105, 176-180.
3. Bahamdan, K. A., Khan, A. R., Tallab, T. M. & Mourad, M. M. (1996). Value of touch preparations (imprints) for diagnosis of cutaneous leishmaniasis. Int J Dermatol 35, 558-560.
4. Berger, R. S., Perez-Figaredo, R. A. & Spielvogel, R. L. (1987). Leishmaniasis: the touch preparation as a rapid means of diagnosis. J Am Acad Dermatol 16, 1096-1105.
5. Bharti, A. R., Nally, J. E., Ricaldi, J. N., Matthias, M. A., Diaz, M. M., Lovett, M. A., Levett, P. N., Gilman, R. H., Willig, M. R. & other authors (2003). Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3, 757-771.
6. Cerqueira, G. M., McBride, A. J., Picardeau, M., Ribeiro, S. G., Moreira, A. N., Morel, V., Reis, M. G., Ko, A. I. & Dellagostin, O. A. (2009). Distribution of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. and application of ligB to typing leptospiral isolates. J Med Microbiol 58, 1173-1181.
7. Ellinghausen, H. C., Jr & McCullough, W. G. (1965). Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. Am J Vet Res 26, 45-51.
8. Faine, S. B., Adler, B., Bolin, C. & Perolat, P. (1999). Leptospira and Leptospirosis, 2nd edn. Melbourne, Australia: MediSci.
9. Faisal, S. M., Yan, W., Chen, C. S., Palaniappan, R. U., McDonough, S. P. & Chang, Y. F. (2008). Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26, 277-287.
10. Faisal, S. M., Yan, W., McDonough, S. P. & Chang, Y. F. (2009). Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 27, 378-387.
11. Gouveia, E. L., Metcalfe, J., de Carvalho, A. L. F., Aires, T. S., Villasboas-Bisneto, J. C., Queirroz, A., Santos, A. C., Salgado, K., Reis, M. G. & Ko, A. I. (2008). Leptospirosis-associated severe pulmonary hemorrhage syndrome, Salvador, Brazil. Emerg Infect Dis 14, 505-508.
12. Haake, D. A., Mazel, M. K., McCoy, A. M., Milward, F., Chao, G., Matsunaga, J. & Wagar, E. A. (1999). Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67, 6572-6582.
13. Jan, I. S., Chung, P. F., Wang, J. Y., Weng, M. H., Hung, C. C. & Lee, L. N. (2008). Cytological diagnosis of Penicillium marneffei infection. J Formos Med Assoc 107, 443-447.
14. Johnson, R. C. & Harris, V. G. (1967). Differentiation of pathogenic and saprophytic leptospires. I. Growth at low temperatures. J Bacteriol 94, 27-31.
15. Kar, K. (1995). Serodiagnosis of leishmaniasis. Crit Rev Microbiol 21, 123-152.
16. Ko, A. I., Galvao Reis, M., Ribeiro Dourado, C. M., Johnson, W. D., Jr & Riley, L. W. (1999). Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354, 820-825.
17. Koizumi, N. & Watanabe, H. (2004). Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22, 1545-1552.
18. Koizumi, N. & Watanabe, H. (2005). Leptospirosis vaccines: past, present, and future. J Postgrad Med 51, 210-214.
19. Landis, J. R. & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics 33, 159-174.
20. Levett, P. N. (2001). Leptospirosis. Clin Microbiol Rev 14, 296-326.
21. Marotto, P. C., Nascimento, C. M., Eluf-Neto, J., Marotto, M. S., Andrade, L., Sztajnbok, J. & Seguro, A. C. (1999). Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 29, 1561-1563.
22. Matsunaga, J., Barocchi, M. A., Croda, J., Young, T. A., Sanchez, Y., Siqueira, I., Bolin, C. A., Reis, M. G., Riley, L. W. & other authors (2003). Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 49, 929-945.
23. McBride, A. J., Athanazio, D. A., Reis, M. G. & Ko, A. I. (2005). Leptospirosis. Curr Opin Infect Dis 18, 376-386.
24. McBride, A. J., Cerqueira, G. M., Suchard, M. A., Moreira, A. N., Zuerner, R. L., Reis, M. G., Haake, D. A., Ko, A. I. & Dellagostin, O. A. (2009). Genetic diversity of the leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol 9, 196-205.
25. Nascimento, A. L., Ko, A. I., Martins, E. A., Monteiro-Vitorello, C. B., Ho, P. L., Haake, D. A., Verjovski-Almeida, S., Hartskeerl, R. A., Marques, M. V. & other authors (2004). Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 186, 2164-2172.
26. Olsen, I. & Stenderup, A. (1990). Clinical-mycologic diagnosis of oral yeast infections. Acta Odontol Scand 48, 11-18.
27. Palaniappan, R. U., Chang, Y. F., Chang, C. F., Pan, M. J., Yang, C. W., Harpending, P., McDonough, S. P., Dubovi, E., Divers, T. & other authors (2005). Evaluation of Lig-based conventional and real time PCR for the detection of pathogenic leptospires. Mol Cell Probes 19, 111-117.
28. Palaniappan, R. U., McDonough, S. P., Divers, T. J., Chen, C. S., Pan, M. J., Matsumoto, M. & Chang, Y. F. (2006). Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74, 1745-1750.
29. Park, S. K., Lee, S. H., Rhee, Y. K., Kang, S. K., Kim, K. J., Kim, M. C., Kim, K. W. & Chang, W. H. (1989). Leptospirosis in Chonbuk Province of Korea in 1987: a study of 93 patients. Am J Trop Med Hyg 41, 345-351.
30. Roscoe, M. (2005). Leishmaniasis: early diagnosis is key. JAAPA 18, 47-50, 53-44.
31. Seder, R. A. & Mascola, J. R. (2003). Basic immunology of vaccine development. In The Vaccine Book, pp. 51-72. Edited by B. R. Bloom & P.-H. Lambert. San Diego: Academic Press.
32. Silva, E. F., Medeiros, M. A., McBride, A. J., Matsunaga, J., Esteves, G. S., Ramos, J. G., Santos, C. S., Croda, J., Homma, A. & other authors (2007). The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25, 6277-6286.
33. Silva, E. F., Santos, C. S., Athanazio, D. A., Seyffert, N., Seixas, F. K., Cerqueira, G. M., Fagundes, M. Q., Brod, C. S., Reis, M. G. & other authors (2008). Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 26, 3892-3896.
34. Silverman, J. F. & Gay, R. M. (1995). Fine-needle aspiration and surgical pathology of infectious lesions. Morphologic features and the role of the clinical microbiology laboratory for rapid diagnosis. Clin Lab Med 15, 251-278.
35. Sonrier, C., Branger, C., Michel, V., Ruvoen-Clouet, N., Ganiere, J. P. & Andre-Fontaine, G. (2000). Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine 19, 86-94.
36. Teixeira, A. C., Paes, M. G., Guerra Jde, O., Prata, A. & Silva-Vergara, M. L. (2008). Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil. Rev Inst Med Trop Sao Paulo 50, 157-160.
37. Volpini, A. C., Marques, M. J., Lopes dos Santos, S., Machado-Coelho, G. L., Mayrink, W. & Romanha, A. J. (2006). Leishmania identification by PCR of Giemsa-stained lesion imprint slides stored for up to 36 years. Clin Microbiol Infect 12, 815-818.
38. WHO & ILS (2003). Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Malta: World Health Organization.
39. Yan, W., Faisal, S. M., McDonough, S. P., Divers, T. J., Barr, S. C., Chang, C. F., Pan, M. J. & Chang, Y. F. (2009). Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 11, 230-237.